financetom
Business
financetom
/
Business
/
Shortage of Applicants, Mismatched Job Expectations Are Some Key Hiring Challenges for Canada's Small Firms, Says CFIB
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Shortage of Applicants, Mismatched Job Expectations Are Some Key Hiring Challenges for Canada's Small Firms, Says CFIB
Jun 10, 2025 5:32 AM

08:04 AM EDT, 06/10/2025 (MT Newswires) -- Canadian small businesses face a shortage of applicants, skills mismatches and difficulty attracting candidates when hiring skilled workers, and these challenges are only worsened by labor mobility barriers, finds recent analysis by the Canadian Federation of Independent Business.

"Over four in ten small firms say a shortage of skilled labour is limiting their ability to increase sales or production. Many are struggling not just to find workers, but to find candidates with the right skills, expectations, and qualifications," said Marvin Cruz, CFIB's director of research, in a note published Tuesday.

Over two-thirds (69%) of small- and medium-sized companies said the primary obstacle to recruiting skilled employees is a shortage of qualified candidates within their sectors. More than half (54%) of small businesses had issues attracting qualified candidates at all, while 47% said they struggled with a mismatch between the skills applicants bring and the actual requirements of the role, accoring to CFIB.

Even when qualified workers are available elsewhere in Canada, provincial licensing and certification barriers often prevent employers from filling essential roles quickly and efficiently-especially in rural areas or sectors where candidates are scarce.

Additionally, 57% of small businesses reported a disconnect between what candidates expect in terms of pay or benefits and what the business is offering, and half of small businesses said they simply cannot provide compensation packages that match those of large companies.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
CarGurus Insider Sold Shares Worth $666,538, According to a Recent SEC Filing
CarGurus Insider Sold Shares Worth $666,538, According to a Recent SEC Filing
Dec 3, 2024
04:42 PM EST, 12/03/2024 (MT Newswires) -- Samuel Zales, COO and President, on December 02, 2024, sold 17,666 shares in CarGurus ( CARG ) for $666,538. Following the Form 4 filing with the SEC, Zales Samuel has control over a total of 442,321 shares of the company, with 442,321 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1494259/000112760224028456/xslF345X05/form4.xml ...
Allegion Insider Sold Shares Worth $343,933, According to a Recent SEC Filing
Allegion Insider Sold Shares Worth $343,933, According to a Recent SEC Filing
Dec 3, 2024
04:47 PM EST, 12/03/2024 (MT Newswires) -- Tracy L Kemp, Senior Vice President, Chief Information & Digital Officer, on December 02, 2024, sold 2,466 shares in Allegion ( ALLE ) for $343,933. Following the Form 4 filing with the SEC, Kemp has control over a total of 9,781 shares of the company, with 9,781 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1579241/000112760224028469/xslF345X05/form4.xml...
Salesforce Tops Third-Quarter Revenue Views, Updates Full-Year Outlook
Salesforce Tops Third-Quarter Revenue Views, Updates Full-Year Outlook
Dec 3, 2024
04:47 PM EST, 12/03/2024 (MT Newswires) -- Salesforce ( CRM ) late Tuesday reported fiscal third-quarter revenue that surpassed Wall Street's estimates amid gains in subscription and support sales. Revenue gained 8% to $9.44 billion, above the $9.35 billion consensus compiled by FactSet. Adjusted per-share earnings rose to $2.41 during the three months ended Oct. 31 from $2.11 a year...
Theratechnologies Resumes Production of EGRIFTA SV
Theratechnologies Resumes Production of EGRIFTA SV
Dec 3, 2024
04:46 PM EST, 12/03/2024 (MT Newswires) -- Theratechnologies ( THTX ) , a biopharmaceutical company, after close Tuesday said production of EGRIFTA SV has resumed following a voluntary shutdown of the company's contract manufacturer's facility to address observations from an inspection by the U.S. Food and Drug Administration (FDA). One newly manufactured batch of EGRIFTA SV, used to treat excess...
Copyright 2023-2026 - www.financetom.com All Rights Reserved